February 2026
1. CHECK JH, Check DL, Ganpo-Nkewnkwa N
   Marked Palliative Benefits Seen With Treatment of Very Advanced Breast Cancer With the Progesterone Receptor Modulator Mifepristone.
   Anticancer Res. 2026;46:1153-1165.
   

   >> Share

   
   December 2025
2. CHECK JH, Check DL, Wilson C
   Good Quality 66.7% 5-year Overall Survival in Terminal Lung Cancer Patients Treated With Mifepristone.
   Anticancer Res. 2025;45:5785-5798.
   

   >> Share

   
   January 2025
3. SATO A, Yabuki A, Sato G, Nemoto H, et al
   Garlic (Allium sativum L.) Organosulfur Compounds Inhibit Breast Cancer Cell Proliferation by Decreasing Steroid Sulfatase Levels.
   Anticancer Res. 2025;45:145-152.
   

   >> Share

   
   February 2024
4. CHECK JH, Check DL, DO TP, Srivastava M, et al
   Significant Palliative Benefits Following Therapy With Mifepristone for Advanced Treatment Resistant Small Cell Lung Cancer.
   Anticancer Res. 2024;44:659-664.
   

   >> Share

   
   August 2023
5. KOROSUE M, Nakagawa K, Yoshiyasu K, Narita S, et al
   Medroxyprogesterone as the Initial Systemic Treatment of Recurrent Endometrial Cancer: A Single Institutional Study.
   Anticancer Res. 2023;43:3693-3699.
   

   >> Share

   
   June 2023
6. KANGA KJW, Kanga LHB, Mendonca P, Soliman KFA, et al
   Attenuative Effect of Diallyl Trisulfide on Caspase Activity in TNF-alpha-induced Triple Negative Breast Cancer Cells.
   Anticancer Res. 2023;43:2393-2405.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share